In the study presented here, we show that nearly all actively migrating tumor cells isolated from patient-derived human breast tumors have active TGF-β signaling, and that functional blocking of this signaling leads to significantly decreased invasion and hematogenous dissemination in vivo. The gene discussed is TGFB1; the disease is neoplasm.